EVAN GROVENSTEIN: Open Payments
NPI 1174184030 · COLBERT, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,285 in 69 payments from 20 companies in 2025. Trend: 2023 $543 · 2024 $691 · 2025 $1,285
Food & beverage: $1,285
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $225 |
| Alkermes, Inc. | 7 | $146 |
| Vanda Pharmaceuticals Inc. | 7 | $137 |
| Axsome Therapeutics, Inc. | 5 | $112 |
| Teva Pharmaceuticals USA, Inc. | 6 | $100 |
| Corcept Therapeutics | 4 | $78 |
| ABBVIE INC. | 4 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $77 |
| Lundbeck LLC | 2 | $55 |
| Exact Sciences Corporation | 2 | $43 |
Products named: CAPLYTA, REXULTI, ARISTADA, Auvelity, FANAPT, AUSTEDO XR, Korlym, HETLIOZ.
Industry payments across GA — which companies pay providers there.
